Mastermind Session: Atlas: Mapping Global Therapeutic Isotope Availability to Accelerate Smarter Trial Placement & TRP Development Strategy

11:00 am - Tuesday 1st December 2026

Identifying where key therapeutic isotopes including Actinium, Lutetium, Lead, Copper and emerging radionuclides are currently being produced and made available for clinical development globally
Understanding how isotope availability, regional infrastructure and manufacturing capacity are increasingly influencing where companies place Phase I – III radiopharmaceutical trials
Comparing the evolving radiopharmaceutical ecosystems globally to assess which regions are best positioned to support future TRPs